In defence of polypharmacy

Editorial

J K Aronson. Br J Clin Pharmacol. 2004 Feb.

. 2004 Feb;57(2):119-20.

doi: 10.1111/j.1365-2125.2004.02067.x.

No abstract available

Comment on

Adverse drug reactions in elderly patients.
Routledge PA, O'Mahony MS, Woodhouse KW. Routledge PA, et al. Br J Clin Pharmacol. 2004 Feb;57(2):121-6. doi: 10.1046/j.1365-2125.2003.01875.x. Br J Clin Pharmacol. 2004. PMID: 14748810 Free PMC article. Review.
Application of data mining techniques in pharmacovigilance.
Wilson AM, Thabane L, Holbrook A. Wilson AM, et al. Br J Clin Pharmacol. 2004 Feb;57(2):127-34. doi: 10.1046/j.1365-2125.2003.01968.x. Br J Clin Pharmacol. 2004. PMID: 14748811 Free PMC article. Review.
Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1.
Blakey GE, Lockton JA, Perrett J, Norwood P, Russell M, Aherne Z, Plume J. Blakey GE, et al. Br J Clin Pharmacol. 2004 Feb;57(2):162-9. doi: 10.1046/j.1365-2125.2003.01973.x. Br J Clin Pharmacol. 2004. PMID: 14748815 Free PMC article. Clinical Trial.

1. Watson G. A Study in Therapeutics. London: Wellcome Historical Medical Library; 1966. Theriac and Mithridatium.
1. Aronson JK. An Account of the Foxglove and its Medical Uses. Oxford: Oxford University Press; 1985. pp. 1785–1985. 268.
1. Standl E, Fuchtenbusch M. The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus. Diabetologia. 2003;46(Suppl 1):M30–6. - PubMed
1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80% Br Med J. 2003;326:1419–23. - PMC - PubMed
1. Movig KL, Leufkens HG, Lenderink AW, Van den Akker VG, Hodiamont PP, Goldschmidt HM, Egberts AC. Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol. 2002;53:363–9. - PMC - PubMed